SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells

Oncology Reports

Volumn 26, Issue 5, 2011, Pages 1115-1120

  Lei, Ke Feng ^a,b   Liu, Bing Ya ^a   Wang, Yan Fang ^c   Chen, Xue Hua ^a   Yu, Bei Qin ^a   Guo, Yan ^a   Zhu, Zheng Gang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

FBXO32; Gastric cancer; KHDRBS3; Serine protease inhibitor B5; Yeast two hybrid

Indexed keywords

ATROGIN 1; MESSENGER RNA; PROTEIN KHDRBS3; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR B5; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DDX18 GENE; DISEASE ASSOCIATION; FBXO32 GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KHDRBS3 GENE; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SCREENING TEST; STOMACH CANCER; STOMACH CARCINOGENESIS; TTK GENE; TWO HYBRID SYSTEM; WESTERN BLOTTING;

BASE SEQUENCE; CELL LINE, TUMOR; HUMANS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA-BINDING PROTEINS; SERPINS; SKP CULLIN F-BOX PROTEIN LIGASES; STOMACH NEOPLASMS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 80053168412     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1369     Document Type: Article

References (29)

1. Zou Z, Anisowicz A, Hendrix MJ, et al: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529, 1994. (Pubitemid 24082753)
2. Kim SM, Cho SJ, Jang WY, et al: Expression of maspin is associated with the intestinal type of gastric adenocarcinoma. Cancer Res Treat 37: 228-232, 2005.
3. Song SY, Son HJ, Kim MH, Nam ES, Rhee JC and Park C: Prognostic significance of maspin expression in human gastric adenocarcinoma. Hepatogastroenterology 54: 973-976, 2007.
4. Lei KF, Wang YF, Zhu XQ, et al: Identification of MSRA gene on chromosome 8p as a candidate metastasis suppressor for human hepatitis B virus-positive hepatocellular carcinoma. BMC Cancer 7: 172, 2007.
5. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
6. Qu Y, Li JF, Cai Q, et al: Over-expression of FRZB in gastric cancer cell suppresses proliferation and induces differentiation. J Cancer Res Clin Oncol 134: 353-364, 2008. (Pubitemid 351170057)
7. Zheng PZ, Wang KK, Zhang QY, et al: Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/ apoptosis of promyelocytic leukemia. Proc Natl Acad Sci USA 102: 7653-7658, 2005.
8. Du Y, Wang K, Fang H, et al: Coordination of intrinsic, extrinsic, and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia. Blood 107: 1582-1590, 2006. (Pubitemid 43242397)
9. Jedamzik B and Eckmann CR: Analysis of RNA-protein complexes by RNA coimmunoprecipitation and RT-PCR analysis from Caenorhabditis elegans. Cold Spring Harb Protoc 2009: pdb prot5300, 2009.
10. Fields S and Song O: A novel genetic system to detect protein-protein interactions. Nature 340: 245-246, 1989. (Pubitemid 19171591)
11. Chien CT, Bartel PL, Sternglanz R and Fields S: The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc Natl Acad Sci USA 88: 9578-9582, 1991. (Pubitemid 21915674)
12. Parrish JR, Gulyas KD and Finley RL Jr: Yeast two-hybrid contributions to interactome mapping. Curr Opin Biotechnol 17: 387-393, 2006. (Pubitemid 44163455)
13. Tanowitz M and Von Zastrow M: Identification of protein inter-actions by yeast two-hybrid screening and coimmunoprecipitation. Methods Mol Biol 259: 353-369, 2004.
14. Di Fruscio M, Chen T and Richard S: Characterization of Sam68-like mammalian proteins SLM-1 and SLM-2: SLM-1 is a Src substrate during mitosis. Proc Natl Acad Sci USA 96: 2710-2715, 1999. (Pubitemid 29148783)
15. Nigg EA: Nucleocytoplasmic transport: signals, mechanisms and regulation. Nature 386: 779-787, 1997.
16. Galarneau A and Richard S: The STAR RNA binding proteins GLD-1, QKI, SAM68 and SLM-2 bind bipartite RNA motifs. BMC Mol Biol 10: 47, 2009.
17. Lin Q, Taylor SJ and Shalloway D: Specificity and determinants of Sam68 RNA binding. Implications for the biological function of K homology domains. J Biol Chem 272: 27274-27280, 1997. (Pubitemid 27452690)
18. Bailey CM, Khalkhali-Ellis Z, Seftor EA and Hendrix MJ: Biological functions of maspin. J Cell Physiol 209: 617-624, 2006. (Pubitemid 44665678)
19. Sheng S, Truong B, Fredrickson D, Wu R, Pardee AB and Sager R: Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc Natl Acad Sci USA 95: 499-504, 1998. (Pubitemid 28083771)
20. Blacque OE and Worrall DM: Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem 277: 10783-10788, 2002. (Pubitemid 34952831)
21. Bailey CM, Khalkhali-Ellis Z, Kondo S, et al: Mammary serine protease inhibitor (Maspin) binds directly to interferon regulatory factor 6: identification of a novel serpin partnership. J Biol Chem 280: 34210-34217, 2005. (Pubitemid 41443146)
22. Yin S, Li X, Meng Y, et al: Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J Biol Chem 280: 34985-34996, 2005. (Pubitemid 41504634)
23. Yin S, Lockett J, Meng Y, et al: Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res 66: 4173-4181, 2006.
24. Li X, Yin S, Meng Y, Sakr W and Sheng S: Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res 66: 9323-9329, 2006. (Pubitemid 44521155)
25. Luo JL, Tan W, Ricono JM, et al: Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 446: 690-694, 2007. (Pubitemid 46606879)
26. Eitel JA, Bijangi-Vishehsaraei K, Saadatzadeh MR, et al: PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells. Cell Cycle 8: 896-901, 2009.
27. Yeom SY, Jang HL, Lee SJ, et al: Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells. FEBS Lett 584: 1469-1475, 2010.
28. D'Errico M, De Rinaldis E, Blasi MF, et al: Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur J Cancer 45: 461-469, 2009.
29. Terashima M, Maesawa C, Oyama K, et al: Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br J Cancer 92: 1130-1136, 2005. (Pubitemid 40546680)